CARDIOMYOPATHY, HYPERTROPHIC
Clinical trials for CARDIOMYOPATHY, HYPERTROPHIC explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, HYPERTROPHIC trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, HYPERTROPHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart procedure may beat drugs for deadly rhythm disorder
Disease control OngoingThis study compares two treatments for ventricular tachycardia (VT), a fast heart rhythm that can be life-threatening, in people with structural heart disease. One treatment is a procedure called catheter ablation, which destroys the tiny area of heart tissue causing the problem.…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New drug shows promise in reversing heart muscle thickening
Disease control OngoingThis study tests the drug mavacamten in 63 adults with a condition that makes the heart muscle too thick, causing symptoms like shortness of breath. The main goal is to see if the drug can shrink the heart muscle and improve heart function over 48 weeks. Participants take the med…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC